Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000903423-11-000482
Filing Date
2011-09-29
Accepted
2011-09-29 12:36:54
Documents
2
Period of Report
2011-09-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 alkermes8ka_0929.htm 8-K/A 68567
2 alkermes8ka161_0929.htm EX-16.1 5676
  Complete submission text file 0000903423-11-000482.txt   76103
Mailing Address TREASURY BUILDING LOWER GRAND CANAL STREET DUBLIN 2 L2 00000
Business Address TREASURY BUILDING LOWER GRAND CANAL STREET DUBLIN 2 L2 00000 00-353-1-649-2000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 0331
Type: 8-K/A | Act: 34 | File No.: 001-35299 | Film No.: 111113929
SIC: 2834 Pharmaceutical Preparations